159 related articles for article (PubMed ID: 21112752)
1. In vitro effects of natural prenyloxycinnamic acids on human cytochrome P450 isozyme activity and expression.
Genovese S; Epifano F; Curini M; Menger D; Zembruski NC; Weiss J
Phytomedicine; 2011 May; 18(7):586-91. PubMed ID: 21112752
[TBL] [Abstract][Full Text] [Related]
2. Desvenlafaxine and venlafaxine exert minimal in vitro inhibition of human cytochrome P450 and P-glycoprotein activities.
Oganesian A; Shilling AD; Young-Sciame R; Tran J; Watanyar A; Azam F; Kao J; Leung L
Psychopharmacol Bull; 2009; 42(2):47-63. PubMed ID: 19629022
[TBL] [Abstract][Full Text] [Related]
3. A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis.
Modugno F; Knoll C; Kanbour-Shakir A; Romkes M
Breast Cancer Res Treat; 2003 Dec; 82(3):191-7. PubMed ID: 14703066
[TBL] [Abstract][Full Text] [Related]
4. Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction.
Wang Y; Jiang YM; Wang YT; Kang JW; Yu T; Zhao HY; Bian BL; Huang M; Bi HC
J Ethnopharmacol; 2014 Oct; 156():175-81. PubMed ID: 25219605
[TBL] [Abstract][Full Text] [Related]
5. Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction.
Bowen WP; Carey JE; Miah A; McMurray HF; Munday PW; James RS; Coleman RA; Brown AM
Drug Metab Dispos; 2000 Jul; 28(7):781-8. PubMed ID: 10859152
[TBL] [Abstract][Full Text] [Related]
6. Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT-PCR.
Caron E; Rioux N; Nicolas O; Lebel-Talbot H; Hamelin BA
J Biochem Mol Toxicol; 2005; 19(6):368-78. PubMed ID: 16421897
[TBL] [Abstract][Full Text] [Related]
7. Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro.
Wandel C; Kim RB; Guengerich FP; Wood AJ
Drug Metab Dispos; 2000 Aug; 28(8):895-8. PubMed ID: 10901697
[TBL] [Abstract][Full Text] [Related]
8. Functional expression, inhibition and induction of CYP enzymes in HepaRG cells.
Turpeinen M; Tolonen A; Chesne C; Guillouzo A; Uusitalo J; Pelkonen O
Toxicol In Vitro; 2009 Jun; 23(4):748-53. PubMed ID: 19328226
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids.
Salminen KA; Meyer A; Jerabkova L; Korhonen LE; Rahnasto M; Juvonen RO; Imming P; Raunio H
Phytomedicine; 2011 Apr; 18(6):533-8. PubMed ID: 20851588
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of human cytochrome P450 and P-glycoprotein-mediated metabolism of some phytochemicals in extracts and formulations of African potato.
Nair VD; Foster BC; Thor Arnason J; Mills EJ; Kanfer I
Phytomedicine; 2007 Aug; 14(7-8):498-507. PubMed ID: 17336049
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and transporter-mediated drug-drug interactions of the endothelin-A receptor antagonist CI-1034.
Sahi J; Sinz MW; Campbell S; Mireles R; Zheng X; Rose KA; Raeissi S; Hashim MF; Ye Y; de Morais SM; Black C; Tugnait M; Keller LH
Chem Biol Interact; 2006 Feb; 159(2):156-68. PubMed ID: 16356485
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes.
Nakajima M; Ohyama K; Nakamura S; Shimada N; Yamazaki H; Yokoi T
Drug Metab Dispos; 1999 Jul; 27(7):792-7. PubMed ID: 10383922
[TBL] [Abstract][Full Text] [Related]
13. Andrographolide and 14-deoxy-11, 12-didehydroandrographolide inhibit cytochrome P450s in HepG2 hepatoma cells.
Ooi JP; Kuroyanagi M; Sulaiman SF; Muhammad TS; Tan ML
Life Sci; 2011 Feb; 88(9-10):447-54. PubMed ID: 21219911
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibitory effects of asiaticoside and madecassoside on human cytochrome P450.
Winitthana T; Niwattisaiwong N; Patarapanich C; Tantisira MH; Lawanprasert S
Toxicol In Vitro; 2011 Jun; 25(4):890-6. PubMed ID: 21349323
[TBL] [Abstract][Full Text] [Related]
15. Identification of the human liver cytochrome P450 isoenzymes responsible for the 5-methylhydroxylation of the novel anti-fibrotic drug AKF-PD.
He X; Luo X; Liu Z; Hu G; Cheng Z
Xenobiotica; 2011 Oct; 41(10):844-50. PubMed ID: 21679010
[TBL] [Abstract][Full Text] [Related]
16. Potential of the novel antiretroviral drug rilpivirine to modulate the expression and function of drug transporters and drug-metabolising enzymes in vitro.
Weiss J; Haefeli WE
Int J Antimicrob Agents; 2013 May; 41(5):484-7. PubMed ID: 23428312
[TBL] [Abstract][Full Text] [Related]
17. Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor.
Zhang Y; Guo X; Lin ET; Benet LZ
Drug Metab Dispos; 1998 Apr; 26(4):360-6. PubMed ID: 9531525
[TBL] [Abstract][Full Text] [Related]
18. Effect of prenatal exposure of deltamethrin on the ontogeny of xenobiotic metabolizing cytochrome P450s in the brain and liver of offsprings.
Johri A; Dhawan A; Lakhan Singh R; Parmar D
Toxicol Appl Pharmacol; 2006 Aug; 214(3):279-89. PubMed ID: 16494911
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam.
Tang J; Amin Usmani K; Hodgson E; Rose RL
Chem Biol Interact; 2004 Apr; 147(3):319-29. PubMed ID: 15135087
[TBL] [Abstract][Full Text] [Related]
20. In vitro assessment of cytochrome P450 inhibition and induction potential of tanespimycin and its major metabolite, 17-amino-17-demethoxygeldanamycin.
Gan J; Liu-Kreyche P; Humphreys WG
Cancer Chemother Pharmacol; 2012 Jan; 69(1):51-6. PubMed ID: 21594721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
